Search

Eidelberg, Andrew, Jordan Axelrad, Victor Chedid, Sarah Ballou, Adam Cheifetz, and Loren G Rabinowitz. 2024. “Sexual Health in Sexual and Gender Minority Patients With Inflammatory Bowel Disease.”. Digestive Diseases and Sciences 69 (3): 743-48.

Gao, Li, Wei Zhang, Lina Zhang, Barbora Gromova, Guanqing Chen, Eva Csizmadia, Cortney Cagle, et al. 2024. “Silencing of Aryl Hydrocarbon Receptor Repressor Restrains Th17 cell Immunity in Autoimmune Hepatitis.”. Journal of Autoimmunity 143: 103162.

El-Dallal, Mohammed, Kelsey L Anderson, Ariana Saroufim, Linda F Wang, Hannah K Systrom, Asahi Hoque, Ravi Teja Pasam, Karim Tarek Osman, Khadija Chaudrey, and Joseph D Feuerstein. 2023. “Patients’ Perspectives on Marijuana Use for Inflammatory Bowel Disease: A Multicenter Survey.”. Annals of Gastroenterology 36 (6): 624-29.

Deyhim, Tina, Adam S Cheifetz, and Konstantinos Papamichael. 2023. “Drug Clearance in Patients With Inflammatory Bowel Disease Treated With Biologics.”. Journal of Clinical Medicine 12 (22).

Campbell, Kirsti A, Scot B Sternberg, James Benneyan, Sarah N Flier, Maelys Amat, Talya Salant, Keishi Nambara, et al. 2024. “Completion Rates and Timeliness of Diagnostic Colonoscopies for Rectal Bleeding in Primary Care.”. Journal of General Internal Medicine 39 (6): 985-91.

Roblin, Xavier, Stéphane Nancey, Konstantinos Papamichael, Gérard Duru, Mathurin Flamand, Sandy Kwiatek, Adam Cheifetz, Nicole Fabien, Mathilde Barrau, and Stephane Paul. 2024. “Higher Serum Infliximab Concentrations Following Subcutaneous Dosing Are Associated With Deep Remission in Patients With Inflammatory Bowel Disease.”. Journal of Crohn’s & Colitis 18 (5): 679-85.

Ballou, Sarah, Prashant Singh, Judy Nee, Vikram Rangan, Johanna Iturrino, Grace Geeganage, Bernd Löwe, et al. 2023. “Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study.”. Gastroenterology 165 (3): 647-655.e4.

De Mello, Munique Kurtz, Natália Sousa Freitas Queiroz, and Konstantinos Papamichael. 2024. “Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (1): 200-201.

Flynn, Duncan J, and Joseph D Feuerstein. 2023. “In H Pylori Infection, Vonoprazan Plus High-Dose Amoxicillin Was Noninferior to B-Quadruple Therapy for Eradication.”. Annals of Internal Medicine 176 (5): JC54.

Cassavaugh, Jessica, Nada Qureshi, Eva Csizmadia, Maria Serena Longhi, Robina Matyal, and Simon C Robson. 2023. “Regulation of Hypoxic-Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury.”. Pharmaceuticals (Basel, Switzerland) 16 (3).